ORBIMED ADVISORS LLC Q3 2019 Filing
Filed November 14, 2019
Portfolio Value
$5.3B
Holdings
113
Report Date
Q3 2019
Filing Type
13F-HR
All Holdings (113 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —MERSANA THERAPEUTICS INC | 1,891,119 | $3.0B | 56.70% | |
| 102 | —MENLO THERAPEUTICS INC | 662,600 | $3.0B | 56.32% | |
| 103 | —CURIS INC | 1,241,494 | $2.8B | 52.77% | |
| 104 | ICPTUSDINTERCEPT PHARMACEUTICALS IN | 32,200 | $2.1B | 40.55% | |
| 105 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 1,350,655 | $2.0B | 38.69% | |
| 106 | —NOVUS THERAPEUTICS INC | 3,183,314 | $2.0B | 37.46% | |
| 107 | SNDXSYNDAX PHARMACEUTICALS INC | 212,000 | $1.6B | 30.06% | |
| 108 | SPROSPERO THERAPEUTICS INC | 140,709 | $1.5B | 28.31% | |
| 109 | CVM1EURCEL SCI CORP | 125,000 | $1.1B | 21.21% | Put |
| 110 | RUBYUSDRUBIUS THERAPEUTICS INC | 100,000 | $785.0M | 14.90% | Put |
| 111 | KALVKALVISTA PHARMACEUTICALS INC | 38,733 | $449.0M | 8.52% | |
| 112 | —BIOLINERX LTD | 69,240 | $183.0M | 3.47% | |
| 113 | —MEDIGUS LTD | 15,000 | $26.0M | 0.49% |
PreviousPage 2 of 2